DAVID NATHANIEL SMITH, MD
NPI 1780780031, individual, Winston Salem, NC, Internal Medicine, Cardiovascular Disease
- Listed on the Medicare revocation list and the SC Medicaid exclusion list since August 30, 2021.
- Medicaid still paid claims in 7 later months, $1,063,751 in total.
- Medicaid dollars per patient on code 80307 ($557 per patient-month) sit in the top 5% of every provider billing that code.
Public list actions
Paid after the action
Months in which Medicaid paid claims for this provider after a public action that should have triggered a screening check. This is a record of payments, not a determination that they were improper.
| list | identity check | action date | window closed | months paid after | first | last | paid after | 12 months before |
|---|---|---|---|---|---|---|---|---|
| Medicare revocation list 424.535(a)(1) noncompliance (not professionally licensed) and 424.535(a)(9) failure to report | Exact NPI, name verified | Aug 30, 2021 | Oct 21, 2027 | 7 | Sep 2021 | Dec 2022 | $1.1M | $2.7M |
| SC Medicaid exclusion list state list extracted from https://www.scdhhs.gov/sites/dhhs/files/08%2027%202026%20sc%20medicaid%20sanctioned%20individuals patricia%20k%20godley.xlsx (pandas claude colmap) | Exact NPI, name verified | Nov 16, 2022 | still open | 1 | Dec 2022 | Dec 2022 | $23K | $246K |
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | DAVID NATHANIEL SMITH, MD |
| Type | Individual |
| Status | Active |
| NPI issued | September 15, 2006, last updated June 29, 2026 |
| Practice location | MEDICAL CENTER BLVD, Winston Salem, NC 27157-5027, 336-716-6674 |
| Specialties | Psychiatry & Neurology, Addiction Psychiatry (2084P0802X, license 1837 NC) Internal Medicine (207R00000X, license 040971 CT) Psychiatry & Neurology, Addiction Psychiatry (2084P0802X, license 040971 CT) Psychiatry & Neurology, Psychiatry (2084P0800X, license 1837 NC) Internal Medicine, Cardiovascular Disease (207RC0000X, primary, license 2007-01837 NC) Psychiatry & Neurology, Psychiatry (2084P0800X, license 040971 CT) Internal Medicine (207R00000X, license 2007-01837 NC) |
Procedures billed
The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.
| code | what it is | paid | share | per patient-month | typical | rank among providers | |
|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $2.9M | 68% | $557 | $146 (top 5% from $318) | 99th percentile | |
| 80307 | Testing for presence of drug, by chemistry analyzers | $1.1M | 25% | $206 | $45 (top 5% from $110) | 99th percentile | |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | $70K | 2% | $115 | $44 (top 5% from $110) | 96th percentile | |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | $58K | 1% | $71 | $60 (top 5% from $133) | 62nd percentile | |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or morehistory of abuse | $46K | 1% | $186 | $88 (top 5% from $210) | too few months to rank | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $42K | 1% | $128 | $75 (top 5% from $185) | 89th percentile | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | $13K | 0% | $39 | $20 (top 5% from $39) | 95th percentile | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | $12K | 0% | $44 | $21 (top 5% from $38) | too few months to rank |
In this area
3 providers in Winston Salem, NC carry an indicator in the public record, with $7.2M at stake between them. The most common is more hours than a day holds, on 2 of them, followed by named in an enforcement record on 1. 1 is tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | ULTIMATE SACRIFICE Winston Salem, NC, ranked 96 | $365K |
|
| 2 | MERIDA VALERA Winston Salem, NC, ranked 712 | $1.7M |
|
| 4 | UMALAKSHMI THOTAKURA Winston Salem, NC, ranked 7446 | $5.2M |
|
Recent enforcement in NC
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
Referral packet
Referral packet: DAVID SMITH
DAVID SMITH (NPI 1780780031) is an individual in Winston Salem, NC. The registry taxonomy is 2084P0802X. It is enrolled in Medicaid in NC. Medicare revoked billing privileges on August 30, 2021 under 42 CFR 424.535(a)(1) noncompliance (not professionally licensed) and 424.535(a)(9) failure to report. The bar on re-enrolling runs to October 21, 2027.
Evidence tier 1: documented action, then payment. Dollars at stake are $1,063,751, taken from the detector that set the tier. Listed on the Medicare revocation list and the SC Medicaid exclusion list since August 30, 2021. Medicaid still paid claims in 7 later months, $1,063,751 in total. Medicaid dollars per patient on code 80307 ($557 per patient-month) sit in the top 5% of every provider billing that code. Medicare revoked billing privileges on August 30, 2021 under 42 CFR 424.535(a)(1) noncompliance (not professionally licensed) and 424.535(a)(9) failure to report.
- 01Evidence tier 1: documented action, then payment. Dollars at stake are $1,063,751, taken from the detector that set the tier. records 2
- 02Listed on the Medicare revocation list and the SC Medicaid exclusion list since August 30, 2021. records 3
- 03Medicaid still paid claims in 7 later months, $1,063,751 in total. records 4
- 04Medicaid dollars per patient on code 80307 ($557 per patient-month) sit in the top 5% of every provider billing that code. records 5
- 05Medicare revoked billing privileges on August 30, 2021 under 42 CFR 424.535(a)(1) noncompliance (not professionally licensed) and 424.535(a)(9) failure to report. The bar on re-enrolling runs to October 21, 2027. records 6
- 06The Medicare revocation list action is dated August 30, 2021. Medicaid then paid $1,063,751 across 7 later months, from September 2021 to December 2022. The screening window closes on October 21, 2027. In the 12 months before the action Medicaid paid $2,674,933. records 7
- 07The SC Medicaid exclusion list action is dated November 16, 2022. Medicaid then paid $23,337 across 1 later month, from December 2022 to December 2022. In the 12 months before the action Medicaid paid $246,274. records 8
- 08Code G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms, was paid $2,912,337 over 24 months. That is 68% of this provider's Medicaid dollars. It runs at $557 per patient-month. That ranks at the 99th percentile of all providers billing this code, where the typical figure is $146. records 9
- 09Code 80307, Testing for presence of drug, by chemistry analyzers, was paid $1,079,222 over 24 months. That is 25% of this provider's Medicaid dollars. It runs at $206 per patient-month. That ranks at the 99th percentile of all providers billing this code, where the typical figure is $45. records 10
- 10Code 99213, Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more, was paid $70,293 over 14 months. That is 2% of this provider's Medicaid dollars. It runs at $115 per patient-month. That ranks at the 96th percentile of all providers billing this code, where the typical figure is $44. records 11
- 11Code 99214, Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more, was paid $57,525 over 26 months. That is 1% of this provider's Medicaid dollars. It runs at $71 per patient-month. That ranks at the 62nd percentile of all providers billing this code, where the typical figure is $60. records 12
- 12Code 99215, Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more, was paid $46,306 over 5 months. That is 1% of this provider's Medicaid dollars. It runs at $186 per patient-month. This code family has a history of abuse. records 13
- 13Code U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r, was paid $42,000 over 6 months. That is 1% of this provider's Medicaid dollars. It runs at $128 per patient-month. That ranks at the 89th percentile of all providers billing this code, where the typical figure is $75. records 14
Route to the health plan special investigations unit, and to the state Medicaid program integrity unit where the payer is a Medicaid managed care plan, for a records request and a screening check under 42 CFR 455.436. Consider a pre-payment review pending that check; a payment suspension under 42 CFR 455.23 requires the state's own credible-allegation determination. Verify every fact against the cited rows before any action. This packet is a screening product, not a finding.
| program | code | what it is | paid | share | comparison |
|---|---|---|---|---|---|
| Medicaid | G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $2.9M | 68% | 99th percentile of providers on this code ($557 per patient-month, typical $146) |
| Medicaid | 80307 | Testing for presence of drug, by chemistry analyzers | $1.1M | 25% | 99th percentile of providers on this code ($206 per patient-month, typical $45) |
| Medicaid | 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | $70K | 2% | 96th percentile of providers on this code ($115 per patient-month, typical $44) |
| Medicaid | 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | $58K | 1% | 62nd percentile of providers on this code ($71 per patient-month, typical $60) |
| Medicaid | 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or morehistory of abuse | $46K | 1% | |
| Medicaid | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $42K | 1% | 89th percentile of providers on this code ($128 per patient-month, typical $75) |
- A revocation can be reversed on appeal or through a corrective action plan; confirm the current enrollment status with the state and in PECOS before acting.
- State lists carry reinstatements and administrative terminations; confirm the action type with the listing agency.
Sources, 14 public records
- 1. national provider registry: DAVID SMITH (NPI 1780780031) is an individual in Winston Salem, NC. The registry taxonomy is 2084P0802X. It is enrolled in Medicaid in NC.
- 2. Verity risk tier: Evidence tier 1: documented action, then payment. Dollars at stake are $1,063,751, taken from the detector that set the tier.
- 3. Verity risk tier: Listed on the Medicare revocation list and the SC Medicaid exclusion list since August 30, 2021.
- 4. Verity risk tier: Medicaid still paid claims in 7 later months, $1,063,751 in total.
- 5. Verity risk tier: Medicaid dollars per patient on code 80307 ($557 per patient-month) sit in the top 5% of every provider billing that code.
- 6. Medicare revocation list: Medicare revoked billing privileges on August 30, 2021 under 42 CFR 424.535(a)(1) noncompliance (not professionally licensed) and 424.535(a)(9) failure to report. The bar on re-enrolling runs to October 21, 2027.
- 7. paid after a list action: The Medicare revocation list action is dated August 30, 2021. Medicaid then paid $1,063,751 across 7 later months, from September 2021 to December 2022. The screening window closes on October 21, 2027. In the 12 months before the action Medicaid paid $2,674,933.
- 8. paid after a list action: The SC Medicaid exclusion list action is dated November 16, 2022. Medicaid then paid $23,337 across 1 later month, from December 2022 to December 2022. In the 12 months before the action Medicaid paid $246,274.
- 9. procedures billed, Medicaid: Code G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms, was paid $2,912,337 over 24 months. That is 68% of this provider's Medicaid dollars. It runs at $557 per patient-month. That ranks at the 99th percentile of all providers billing this code, where the typical figure is $146.
- 10. procedures billed, Medicaid: Code 80307, Testing for presence of drug, by chemistry analyzers, was paid $1,079,222 over 24 months. That is 25% of this provider's Medicaid dollars. It runs at $206 per patient-month. That ranks at the 99th percentile of all providers billing this code, where the typical figure is $45.
- 11. procedures billed, Medicaid: Code 99213, Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more, was paid $70,293 over 14 months. That is 2% of this provider's Medicaid dollars. It runs at $115 per patient-month. That ranks at the 96th percentile of all providers billing this code, where the typical figure is $44.
- 12. procedures billed, Medicaid: Code 99214, Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more, was paid $57,525 over 26 months. That is 1% of this provider's Medicaid dollars. It runs at $71 per patient-month. That ranks at the 62nd percentile of all providers billing this code, where the typical figure is $60.
- 13. procedures billed, Medicaid: Code 99215, Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more, was paid $46,306 over 5 months. That is 1% of this provider's Medicaid dollars. It runs at $186 per patient-month. This code family has a history of abuse.
- 14. procedures billed, Medicaid: Code U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r, was paid $42,000 over 6 months. That is 1% of this provider's Medicaid dollars. It runs at $128 per patient-month. That ranks at the 89th percentile of all providers billing this code, where the typical figure is $75.